NCT00943800 · OUTCOME

Overall Survival- Percentage of Participants Who Survived at 2 Years and 5 Years

Combined Haploidentical-Cord Blood Transplantation for Adults and Children · Source last updated 2021-01-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: percentage of patients
Interval / dispersion: 95% Confidence Interval
Time frame: up to 5 years

What was measured

We reported overall survival at 2 years and 5 years after transplant

Groups in this outcome

Treatment Group

Although the protocol initially had different disease intensities, ultimately, moved to one regimen for all patients. Subjects received 30mg/m\^2 of Fludarabine from Day-7 until Day-3, 140mg/m\^2 of Melphalan on Day-2, and 1.5mg/kg of Rabbit antithymocyte globulin at Day-7,-5,-3 and -1."

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Treatment Group	87

Reported measurements

Two-year overall survival

Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
Group	Value	Spread	Lower	Upper	Comment
Treatment Group	43.7	Not reported	34.4	55.4	Not reported

Five-year overall survival

Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
Group	Value	Spread	Lower	Upper	Comment
Treatment Group	32.9	Not reported	24.3	44.5	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
34.4
upper Limit
55.4
value
43.7
title
Two-year overall survival
categories
measurements
group Id
OG000
lower Limit
24.3
upper Limit
44.5
value
32.9
title
Five-year overall survival

denoms

counts
group Id
OG000
value
87
units
Participants

description

We reported overall survival at 2 years and 5 years after transplant

dispersion Type

95% Confidence Interval

groups

description
Although the protocol initially had different disease intensities, ultimately, moved to one regimen for all patients. Subjects received 30mg/m\^2 of Fludarabine from Day-7 until Day-3, 140mg/m\^2 of Melphalan on Day-2, and 1.5mg/kg of Rabbit antithymocyte globulin at Day-7,-5,-3 and -1."
id
OG000
title
Treatment Group

param Type

NUMBER

reporting Status

POSTED

time Frame

up to 5 years

title

Overall Survival- Percentage of Participants Who Survived at 2 Years and 5 Years

type

SECONDARY

unit Of Measure

percentage of patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice